60 related articles for article (PubMed ID: 3589291)
1. [Transdermal estradiol substitution in the postmenopause, individual dosage adjustment and effectiveness in the treatment of climacteric symptoms].
Schenkel L; von Graffenried A
Schweiz Rundsch Med Prax; 1987 Mar; 76(14):358-61. PubMed ID: 3589291
[No Abstract] [Full Text] [Related]
2. [Splenopeptides for climacteric complaints. Comparison of ovarian stimulation with transdermal estradiol substitution].
Lauritzen C; Teucher T; Schmitz H
Arzneimittelforschung; 1995 Mar; 45(3):315-22. PubMed ID: 7741793
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of transdermal and subcutaneous administration of estradiol in the treatment of climacteric symptoms].
van Leusden HA
Ned Tijdschr Geneeskd; 1987 Dec; 131(50):2301-4. PubMed ID: 3696269
[No Abstract] [Full Text] [Related]
4. [Transdermal estradiol--the possibility for replacement therapy in the postmenopause].
Rachev E
Akush Ginekol (Sofiia); 1994; 33(3):45-7. PubMed ID: 7793531
[TBL] [Abstract][Full Text] [Related]
5. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of transdermal with oral hormone substitution: a multicenter study with a new matrix patch].
Sajtos B; Herold J; Winkler UH; Schindler AE
Zentralbl Gynakol; 1995; 117(10):524-30. PubMed ID: 7491835
[TBL] [Abstract][Full Text] [Related]
7. [Transdermal and oral hormone substitution with estrogens: a comparison].
Schindler AE
Zentralbl Gynakol; 1995; 117(10):504-7. PubMed ID: 7491831
[TBL] [Abstract][Full Text] [Related]
8. [Subdermal implantation of estradiol 17 beta (25 mg) in hysterectomized and ovariectomized women. Effects of increased serum estradiol level and neurovegetative climacteric complaints].
Tsvetkov Ts; Tsvetkov K; Petkova U
Akush Ginekol (Sofiia); 2001; 41 Suppl 4():11-2. PubMed ID: 11519312
[No Abstract] [Full Text] [Related]
9. [Kinetics of a new patch for transdermal administration of 17 beta-estradiol].
Rohr UD; Nauert C; Ehrly AM
Zentralbl Gynakol; 1995; 117(10):531-9. PubMed ID: 7491836
[TBL] [Abstract][Full Text] [Related]
10. [Clinical effectiveness of a new matrix plaster: an overview].
Schindler AE; Schindler EM
Zentralbl Gynakol; 1995; 117(10):508-9. PubMed ID: 7491832
[No Abstract] [Full Text] [Related]
11. Plasma leptin in postmenopausal women with coronary artery disease: effect of transdermal 17beta-estradiol and intermittent medroxyprogesterone acetate.
Os I; Os A; Abdelnoor M; Larsen A; Birkeland K; Westheim A
Climacteric; 2003 Sep; 6(3):204-10. PubMed ID: 14567768
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of disorders of the climacteric by vaginal, rectal and transdermal estrogen substitution].
Lauritzen C
Gynakologe; 1986 Dec; 19(4):248-53. PubMed ID: 3817597
[No Abstract] [Full Text] [Related]
13. The effect of a novel vaginal ring delivering oestradiol acetate on climacteric symptoms in postmenopausal women.
Buckler H; Al-Azzawi F;
BJOG; 2003 Aug; 110(8):753-9. PubMed ID: 12892687
[TBL] [Abstract][Full Text] [Related]
14. Do different delivery systems of hormone therapy have different effects on psychological symptoms in surgically menopausal women? A randomized controlled trial.
Baksu B; Baksu A; Göker N; Citak S
Maturitas; 2009 Feb; 62(2):140-5. PubMed ID: 19179026
[TBL] [Abstract][Full Text] [Related]
15. The effects of transdermal estradiol and oral conjugated estrogens on haemostasis variables.
Kroon UB; Silfverstolpe G; Tengborn L
Thromb Haemost; 1994 Apr; 71(4):420-3. PubMed ID: 8052956
[TBL] [Abstract][Full Text] [Related]
16. Dose dependent response of symptoms, pituitary, and bone to transdermal oestrogen in postmenopausal women.
Stevenson JC; Shennan NM; Whitehead MI
Br Med J (Clin Res Ed); 1987 Jan; 294(6565):181. PubMed ID: 3109564
[No Abstract] [Full Text] [Related]
17. Effects on climacteric symptoms, bone and lipoprotein metabolism of hormone replacement therapy delivered by estradiol-releasing intravaginal rings: a pilot study.
Farish E; Barnes JF; Rankin M; Hart DM
Climacteric; 2003 Sep; 6(3):211-20. PubMed ID: 14567769
[TBL] [Abstract][Full Text] [Related]
18. [A transdermal therapeutic estradiol system for physiological hormone substitution in the menopause].
Schenkel L
Schweiz Rundsch Med Prax; 1985 Mar; 74(11):277-82. PubMed ID: 3887536
[No Abstract] [Full Text] [Related]
19. Effects of ultralow-dose transdermal estradiol on postmenopausal symptoms in women aged 60 to 80 years.
Diem S; Grady D; Quan J; Vittinghoff E; Wallace R; Hanes V; Ensrud K
Menopause; 2006; 13(1):130-8. PubMed ID: 16607109
[TBL] [Abstract][Full Text] [Related]
20. [Transdermal estrogen substitution in the climacteric syndrome].
Melchert F; Schenkel L; Asche H
Med Monatsschr Pharm; 1988 Jan; 11(2):88-90. PubMed ID: 3357481
[No Abstract] [Full Text] [Related]
[Next] [New Search]
